Skip to content

AtheroNova Inc.

company.status.inactive

CIK 1377053fmd_0D19D1N22Q29QGS2YTVDZNCQQEManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2008 to Sep 30, 2014, 22 periods

Latest annual · FY2013

Millions
Total revenues
0
Operating income
(4)
Net income
(8)

Latest quarter · Q3 FY2014

Millions
Total revenues
0
Net income
(3)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2010 to FY2013
n/m
Revenue, 5 yearsFY2008 to FY2013
n/m
Net income, 5 yearsFY2008 to FY2013
n/m

AtheroNova Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2013FY2012ChangeSource
Revenue$0$010-K 2014-02-27 · proof
Net income-$7.8 million-$2.6 million10-K 2014-02-27 · proof
Cash from operating activities-$3.3 million-$2.1 million10-K 2014-02-27 · proof
Total assets$308,830$2.8 million-88.9%10-K 2014-02-27 · proof
Total liabilities$2.8 million$1 million+180.8%10-K 2014-02-27 · proof
Cash and cash equivalents$266,210$2.7 million-90.3%10-K 2014-02-27 · proof
What was AtheroNova Inc.'s revenue in fiscal 2013?
AtheroNova Inc. reported revenue of $0 for fiscal 2013 (the year ended Dec 31, 2013), against $0 the year before. Source: the 10-K filed with the SEC on Feb 27, 2014. SEC
What was AtheroNova Inc.'s net income in fiscal 2013?
AtheroNova Inc. reported net income of -$7.8 million for fiscal 2013 (the year ended Dec 31, 2013), against -$2.6 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2014. SEC
What was AtheroNova Inc.'s cash from operating activities in fiscal 2013?
AtheroNova Inc. reported cash from operating activities of -$3.3 million for fiscal 2013 (the year ended Dec 31, 2013), against -$2.1 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2014. SEC
What are AtheroNova Inc.'s total assets?
As of Dec 31, 2013, AtheroNova Inc. reported total assets of $308,830, against $2.8 million a year earlier (-88.9%). Source: the 10-K filed with the SEC on Feb 27, 2014. SEC
What are AtheroNova Inc.'s total liabilities?
As of Dec 31, 2013, AtheroNova Inc. reported total liabilities of $2.8 million, against $1 million a year earlier (+180.8%). Source: the 10-K filed with the SEC on Feb 27, 2014. SEC
What are AtheroNova Inc.'s cash and cash equivalents?
As of Dec 31, 2013, AtheroNova Inc. reported cash and cash equivalents of $266,210, against $2.7 million a year earlier (-90.3%). Source: the 10-K filed with the SEC on Feb 27, 2014. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1377053&period_type=annual&limit=5"

Information only, not investment advice.